Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib and Irinotecan in KRAS Mutated Metastatic Colorectal Cancer
NCT01715441Phase 2Completed
- Sponsor
- Institut du Cancer de Montpellier
- Start
- Sep 2012
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in colorectal cancer (CRC), sponsored by Institut du Cancer de Montpellier. Started Sep 2012; status: completed.
02
Drugs
sorafenib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01715441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01715441.